Cargando…
A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol
BACKGROUND: Vascular dementia is the second most common cause of dementia affecting over seven million people worldwide, yet there are no licensed treatments. There is an urgent need for a clinical trial in this patient group. Subcortical ischaemic vascular dementia is the most common variant of vas...
Autores principales: | Greenan, Caroline, Murphy, Lynn, Yu, Ly-Mee, Kehoe, Patrick G., Coulthard, Elizabeth, Bath, Philip, Stewart, Robert, Jones, Rob, Corbett, Anne, Thomas, Alan, Connelly, Peter, Arrojo, Frank, Canning, Rachel, Wallach, Sylvia, Henderson, Catherine, McGuinness, Bernadette, O’Sullivan, Mike, Holmes, Clive, Knapp, Martin, Ballard, Clive, Passmore, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950108/ https://www.ncbi.nlm.nih.gov/pubmed/27430267 http://dx.doi.org/10.1186/s13063-016-1449-3 |
Ejemplares similares
-
From DemenTia to DemenCia: Way More Than a Single Letter
por: Britton, Maggie
Publicado: (2021) -
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013) -
The efficacy of Cognitive training in patients with VAsCular Cognitive Impairment, No dEmentia (the Cog-VACCINE study): study protocol for a randomized controlled trial
por: Tang, Yi, et al.
Publicado: (2016) -
Emics and etics : the insider/outsider debate /
Publicado: (1990) -
Four Years of the EMIC Program
por: Eliot, Martha M., et al.
Publicado: (1947)